Gerresheimer, a manufacturer of special glass and plastic products to the pharmaceutical industry, plans to sell its life-science research business to Duran group, a portfolio company of One Equity Partners, a private equity firm for $131 million. The move is in line with the company’s strategy of focusing on packaging and device solutions for pharmaceutical customers,

The business, Kimble Chase Life Science and Research Products LLC, is based in Rockwood, Tennessee. It is a producer of laboratory and scientific glassware. The product portfolio includes reusable laboratory glassware for research, development and analytics, such as beakers, Erlenmeyer flasks and measuring cylinders as well as disposable laboratory products such as culture tubes, pipettes, chromatography vials and other specialty laboratory glassware.

The deal is is subject to regulatory approvals.

Source: Gerresheimer